Skip to main content

Table 1 Patient’s characteristics at baseline (n=18)

From: Counteracting learned non-use in chronic stroke patients with reinforcement-induced movement therapy

Characteristics

EG n (%)

CG

p-values

Subjects

12 (52 %)

11 (48 %)

 

Dropouts

3 (13 %)

2 (9 %)

 

Compliants

9 (39 %)

9 (39 %)

 

Gender

  

.578

Female

2 (11 %)

1 (6 %)

 

Male

7 (39 %)

8 (44 %)

 

Etiology

  

1.000

Hemorrhagic

1 (6 %)

3 (17 %)

 

Ischemic

8 (44 %)

6 (33 %)

 

Lesion side

  

1.000

Right

5 (28 %)

4 (22 %)

 

Left

4 (22 %)

5 (28 %)

 

Mean (SD) - Median

 

[25th–75th percentiles]

 

Age, years

63.40 (9.40) – 63

54.80 (12.00) – 57

.154

 

[57.80–68.50]

[50.80–63.30]

 

Days

1298.44 (1968.48) – 400

1387.33 (1455.12) – 735

.232

poststroke

[269.25–1373.00]

[493.50 – 1826.00]

 

Clinical scales

   

Total UE-FM

32.33 (16.09) – 38

36.89 (12.29) – 40

.651

 

[25.50–40.75]

[50.80–63.30]

 

UE-FM-Proximal

17.00 (7.40) – 17

18.89 (6.01) – 19

.88

 

[12.50–21.50]

[16.88–21.13]

 

UE-FM-Wrist

5.78 (3.60) – 8

4.78 (3.31) – 5

.49

 

[5.75–10.25]

[2.25–7.75]

 

UE-FM-Hand

7.44 (4.69) – 8

11.44 (4.72) – 12

.15

 

[4.63–11.38]

[8.50–15.50]

 

UE-FM-

2.56 (1.67) – 3

2.78 (1.30) – 3

.99

Coordination

[1.75–4.25]

[2.00–4.00]

 

CAHAI

32.56 (14.47) – 36

36.89 (12.29) – 40

.475

 

[25.50–42.25]

[16.00–45.00]

 

BI

85.33 (10.82) – 88

90.56 (7.32) – 90

.445

 

[80.00–91.00]

[84.00–96.25]

 

Hamilton

14.44 (9.61) – 8

12.44 (9.10) – 10

.649

 

[6.75–24.75]

[5.50–19.50]

 
  1. Statistical test used for p-value: Wilcoxon rank-sum test